title: Doxorubicin release triggered by alginate embedded magnetic nanoheaters: a combined therapy.
authors.affiliation: Inserm, U, Bio-ingénierie Cardiovasculaire, Paris, France.
authors.forename: Séverine
authors.initials: S
authors.lastname: Brulé
authors.forename: Michael
authors.initials: M
authors.lastname: Levy
authors.forename: Claire
authors.initials: C
authors.lastname: Wilhelm
authors.forename: Didier
authors.initials: D
authors.lastname: Letourneur
authors.forename: Florence
authors.initials: F
authors.lastname: Gazeau
authors.forename: Christine
authors.initials: C
authors.lastname: Ménager
authors.forename: Catherine
authors.initials: C
authors.lastname: Le Visage
mesh_terms: D000464:Alginates / Q000737:chemistry*; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage* / Q000737:chemistry; D001943:Breast Neoplasms / Q000188:drug therapy; D045744:Cell Line, Tumor; D003131:Combined Modality Therapy; D004317:Doxorubicin / Q000008:administration & dosage* / Q000737:chemistry; D004337:Drug Carriers / Q000737:chemistry; D005260:Female; D005290:Ferric Compounds / Q000737:chemistry; D020723:Glucuronic Acid / Q000737:chemistry; D006603:Hexuronic Acids / Q000737:chemistry; D006801:Humans; D006979:Hyperthermia, Induced; D008280:Magnetics; D053768:Metal Nanoparticles / Q000737:chemistry; D013696:Temperature
chemical_list: D000464:Alginates; D000903:Antibiotics, Antineoplastic; D004337:Drug Carriers; D005290:Ferric Compounds; D006603:Hexuronic Acids; C000499:ferric oxide; D004317:Doxorubicin; D020723:Glucuronic Acid